Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

The State of Texas, through the Health and Human Services Texas (HHSTX) agency, awarded a contract to Pfizer Inc. on July 6, 2026, for the provision of childhood vaccines. The contract references pricing established under the Center for Disease Control and Prevention (CDC) Federal Contract for Vaccine and Biologicals (CDC Federal Contract Number: 75D30126D20730) and was executed under the authority of Texas Government Code Section 2155.144 for goods acquired for the benefit of clients enrolled in programs operated by the agency. The specific vaccine products covered under this award include botulinum toxin, Haemophilus influenzae b combined with diphtheria, tetanus, and acellular pertussis, smallpox vaccine, pneumococcal vaccine, and pertussis vaccine.

The contract establishes Pfizer Inc. (Pfizer Wyeth) as the prime contractor responsible for supplying these immunobiological products to support the State of Texas' vaccination programs. As a federal pricing agreement, the terms are aligned with existing CDC contracting mechanisms, ensuring standardized pricing and product specifications. The contract classification under NIGP Code 26980 (Serums, Toxoids, and Vaccines) reflects the biological nature of the products being supplied. Specific details regarding contract value, cumulative value, and the defined period of performance were not disclosed in the available documentation.